Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

Urology·2001

Clinical strategy for the development of angiogenesis inhibitors.

The oncologist·2000

Clinical research and drug development of antivirals in HIV: an industry perspective.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1995

Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

NCI monographs : a publication of the National Cancer Institute·1988

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1987

Calibrated phase II clinical trials in oncology.

Statistics in medicine·1986

Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review.

Cancer treatment reviews·2026

Molecular tumor boards implementation in Europe: a scoping review and thematic analysis of challenges and facilitators.

Cancer treatment reviews·2026

Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options.

Cancer treatment reviews·2026

"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions".

Cancer treatment reviews·2026

Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.

Cancer treatment reviews·2026

Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.

Cancer treatment reviews·2026

Optimizing management strategies for T4b esophageal cancer: the role of TEVAR in multimodal treatment approaches.

Scandinavian journal of gastroenterology·2026

Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

Asia-Pacific journal of clinical oncology·2026

[Efficacy of bidirectional switching therapy between adrenal ablation and adrenalectomy in patients with primary aldosteronism].

Zhonghua yi xue za zhi·2026

[Analysis of efficacy and prognostic factors of neoadjuvant chemoradiotherapy in locally advanced mid-low rectal cancer patients with RAS gene mutation].

Zhonghua yi xue za zhi·2026

[Expert consensus on co-ablation therapy for the perioperative management of bone and soft tissue tumors].

Zhonghua nei ke za zhi·2026

Related Experiment Videos

Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy

Related Concept Videos

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

Clinical strategy for the development of angiogenesis inhibitors.

Clinical research and drug development of antivirals in HIV: an industry perspective.

Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

Calibrated phase II clinical trials in oncology.

Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review.

Molecular tumor boards implementation in Europe: a scoping review and thematic analysis of challenges and facilitators.

Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options.

"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions".

Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.

Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.

Optimizing management strategies for T4b esophageal cancer: the role of TEVAR in multimodal treatment approaches.

Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

[Efficacy of bidirectional switching therapy between adrenal ablation and adrenalectomy in patients with primary aldosteronism].

[Analysis of efficacy and prognostic factors of neoadjuvant chemoradiotherapy in locally advanced mid-low rectal cancer patients with RAS gene mutation].

[Expert consensus on co-ablation therapy for the perioperative management of bone and soft tissue tumors].

Related Experiment Videos

Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy

Related Concept Videos

Related Articles